Home/Manhattan Biosolutions/Dr. Nathan Tumey
DN

Dr. Nathan Tumey

Scientific Advisor

Manhattan Biosolutions

Therapeutic Areas

Manhattan Biosolutions Pipeline

DrugIndicationPhase
FGFR4-Targeted ADCCancerPre-clinical
Legumain-Cleavable TOP1i ADCCancerPre-clinical
TxD (Taxoid) ADCCancerPre-clinical
Pritumumab ADCCancerPre-clinical